Services

Your Science Moves Fast. So Should Your Proteins.

Whether you're engineering novel biologics, testing a new therapeutic concept, or simply need reliable protein reagents, Albrem gives you a faster, smarter way to move from idea to result—without sacrificing precision or quality.

Our Solutions are Designed for Speed, Precision, and Reproducibility

At Albrem, we believe that the diagnostics and biologics industries should evolve as fast as the science behind them. That’s why our solutions are built to accelerate the development of high-quality protein reagents—delivered with precision, consistency, and flexibility.

Smart Design Meets Modern Science

We combine modern analytical tools with intelligent target selection strategies and small-language machine learning models to help design reagents that not only perform well but are also optimized for reproducibility. Our approach is tailored to keep up with the evolving needs of biopharma and diagnostics innovation.

What We Offer is Tailored to Your Science

We specialize in the rapid production and characterization of high-performance protein reagents, including:

• Antibodies and antibody derivatives

• Protein fragments and difficult-to-express targets

• Functional proteins

Albrem Biopharma also offers custom well-characterized proteins and reagents.

Well-characterized proteins are essential for the advancement of drugs through all drug development stages, from lead identification to drug approval, as well as through the post approval lifecycle.

• These proteins serve as:
  • Drug development tools
  • Analytical standards
  • Reagents for Bioanalytical Assays
  • Controls for process development, and formulation

At Albrem Biopharma we create high-quality protein reagents for your analytical assays that are based on required key attributes, and ensure they remain stable so your drug stays compliant and your assay results stay reliable even when components change. Our approach reduces risks of discontinuation, lot-to-lot variability, and variability from biological production.

• Albrem Biopharma’s protein reagent approach:
  • Offers custom reagent production and testing
  • Uses cell-free synthesis to ensure consistent, rapid production and prototyping
  • Produces each batch with a defined, reproducible, and well-documented process
  • Improves availability and consistency of critical reagents and standards
  • Provides custom conjugation capabilities when needed for specific assays or testing.
  • Transition and scale to mammalian production as appropriate
• Key elements of the Albrem Biopharma protein production program include:
  • Careful material selection
  • Formulation selection
  • Broad biochemical and analytical testing
  • Alignment with manufacturer systems

Albrem collaboration with Emery Pharma CRO enables synergistic approach to establishment of a GMP or GLP stability program that ensures your critical reagent is suitable as a standard or control during the lifecycle of your product. Emery Pharma Reference Standards (ERS) program provides for GLP/GMP-compliant management of reagent and standard lots.

• Emery Pharma maintains Reference Standards (ERS) to ensure consistent product quality by enabling comparison of test results to a known reference (e.g., HPLC, MS, ELISA, immunogenicity assays).
• Key elements of the Emery Pharma program include:
  • Broad biochemical and analytical testing
  • Validation or qualification of critical stability assays
  • Extensive qualification of replacement lots
  • Ongoing stability monitoring